Issue 12 Executive Interviews
Making the Most of Your Knowledge
While greater access to data provides an opportunity for most organizations, it also represents a challenge in terms of IT. So how can laboratories ensure they are making the most of the scientific knowledge at their disposal? NGP talks to Pat Martell, Director of Waters Laboratory Informatics, to find out.
Making the Best of a Tough Situation
Pharmaceutical companies can find themselves subject to corporate integrity agreements (CIAs) if the government discovers noncompliance of fraud and abuse. NGP asked Jayson Dukes of FTI Consulting what companies can do to help ensure a favorable resolution when subject to a CIA.
The Right Connection
Across the global pharmaceutical industry, companies are waking up to the shortcomings of new drug applications. The cost of research and development (R&D) is rising, while the approval rate of innovative new drugs is declining. Joe Herring, Chairman and CEO of Covance, talks about the role outsourcing plays.
Simplifying Science
NGP spoke with Greg Herrema, President of Scientific Instruments at Thermo Fisher Scientific about integration and innovation.
The Importance of Marketing
Before joining Wyeth Pharmaceuticals as a Product Director, Julie Holcombe spent 15 years as an Advertising Director. Here she shares her thoughts with NGP on the impact of customer relationships, loyalty and the Internet on marketing in pharma.
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.